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Craniofacial malformations are common structural
birth defects and usually associate with abnormal
development of pharyngeal arches. Although some
microRNAs have been found to be implicated in
chondrogenesis in vitro, few have been shown to
be essential for cartilage and bone development at
the whole organism level. In this study, we report
that mir92a is highly enriched in the chondrogenic
progenitors and that its inactivation results in loss
of pharyngeal cartilage elements due to poor
proliferation, impaired differentiation, and unsustain-
able survival of chondrogenic progenitors. The Bmp
antagonist gene noggin3 (nog3) is a direct target of
mir92a. Inactivation of mir92a stabilizes nog3
mRNA, leading to repression of Bmp signaling and
abnormal behaviors of chondrogenic progenitors.
In contrast, ectopic expression of mir92a duplex
decreases nog3 mRNA levels and, as a result, dere-
presses Bmp signaling and promotes cell apoptosis.
Therefore, mir92a acts to maintain Bmp activity
during pharyngeal cartilage formation by targeting
nog3.
INTRODUCTION
Craniofacial malformation is a common congenital birth defect,
which affects the development of head, face, and neck. These
abnormalities result from aberrant patterning and formation of
craniofacial structures (Chai and Maxson, 2006). Most skeletal
elements of the skull, such as bone, cartilage, and teeth, are
derived from cranial neural crest (CNC). CNC cells originate
from neural folds, undergo epithelial to mesenchymal transition
(EMT), and migrate to the craniofacial regions (Donoghue et al.,
2008; Trainor and Nieto, 2003). The postmigratory CNC cells
then start the condensation process, including epithelial-mesen-
chymal tissue interaction, aggregation toward certain centers,
and proliferation to expand chondrogenic progenitors. The
chondrogenic progenitors differentiate into chondrocytes and
surround themselves with extracellular matrix, including
collagen encoded by col2a1 (Hall and Miyake, 1995, 2000).DevelopmThe specification of neural crest is a complex process
controlled by multiple signaling pathways including the Wnt,
Fgf, and Bmp pathways (LaBonne and Bronner-Fraser, 1999;
Nie et al., 2006). Bmp signaling plays a central role in specifying
the neural crest fate at the neural plate border during gastrulation
and neurulation (Pera et al., 1999; Streit and Stern, 1999; Wilson
et al., 1997). In addition to the role in neural crest specification,
Bmp signaling is also required for the proper migration of CNC
(Kanzler et al., 2000; Knecht and Bronner-Fraser, 2002; Tribulo
et al., 2003). During endochondral bone formation, cartilage-
specific deletions of type I receptors Bmpr1a and Bmpr1b or
receptor-activated Smads 1, 5, and 8 cause severe chondrodys-
plasia due to impaired chondrocyte proliferation, differentiation,
and survival (Retting et al., 2009; Yoon et al., 2005). Several Bmp
ligands and their antagonist are expressed in the pharyngeal
arches (Holzschuh et al., 2005; Liu et al., 2005; Paiva et al.,
2010; Patel et al., 2006; Stottmann et al., 2001; Wise and Stock,
2006), but their specific roles in later processes of pharyngeal
cartilage development remain unclear since their multiple roles
in early embryonic development make it difficult to study
stage-specific function at later stages.
microRNAs (miRNAs) are small regulatory RNAs processed
from long primary transcripts and modulate gene expression
mainly at the posttranscriptional level by base-pairing to partial
complementary sites in the 30 untranslated region (30 UTR) of
their target genes (Ambros, 2004; Bartel, 2004). The gene
expression regulation by miRNAs plays a critical role in control-
ling fundamental cellular functions and developmental
processes (Choi et al., 2007; Leucht et al., 2008; Martello et al.,
2007; Reinhart et al., 2000; Zhao et al., 2007). Dicer is an essen-
tial component for biogenesis of miRNAs, and its deficiency in
chondrocytes results in a reduction in the number of proliferating
chondrocytes, suggesting a crucial function of miRNAs in cell
proliferation during cartilage development (Kobayashi et al.,
2008).mir140 is expressed specifically in cartilage tissues during
mouse and zebrafish embryonic development (Eberhart et al.,
2008; Tuddenham et al., 2006; Wienholds et al., 2005) and regu-
lates platelet-derived growth factor (pdgf)-mediated attraction
during migration of neural crest-derived palatal precursors
(Eberhart et al., 2008). The importance of other miRNAs in
craniofacial cartilage development and interrelated diseases
has not been elucidated at the whole animal level.
It has been reported that mir92a increases proliferation of
myeloid cells and hepatocellular carcinoma cells (Manni et al.,
2009; Shigoka et al., 2010) and blocks angiogenesis and vesselental Cell 24, 283–295, February 11, 2013 ª2013 Elsevier Inc. 283
Figure 1. mir92a Expression Pattern and
Knockdown Effect on Head Cartilages in
Zebrafish Embryos
(A) Expression pattern ofmir92a at different stages
as detected by in situ hybridization. The pharyn-
geal region and pectoral fins were indicated by
a red and a black arrowhead, respectively.
(B) Expression of mir92a in pharyngeal arches.
Tg(fli1:EGFP) transgenic embryos at 36–72 hpf
were hybridized withmir92a (red) and GFP (green)
probes, and the signals were amplified with TSA
tetramethylrhodamine. Seven pharyngeal arches
(PA1–7), with dorsal to the right, were labeled in the
middle picture. cb, ceratobranchial; ch, cera-
tohyal; pq, palatoquadrate. The boxed areas in the
images were presented at higher magnification in
the relevant insets. Scale bars, 50 or 10 mm in the
inset.
(C) Morphology of the head inmorphants at 96 hpf.
The pharyngeal region was indicated by an
arrowhead. Lateral views. Each MO was injected
into one-cell stage embryos at the dose of 4 ng.
The ratio of embryos with representative pharyn-
geal cartilage defects (shown) was indicated.
Scale bar, 200 mm.
(D) Head cartilages stained with Alcian blue at
80 hpf. Upper panel, lateral views; lower panel,
dorsal or ventral views. Lower panel showed the pattern of dorsal neurocranium (left picture) and ventral pharyngeal cartilages (middle picture) with labels: ep,
ethmoid plate; tc, trabeculae cranii; pc, parachordal; ac, auditory capsule; abc, anterior basicranial commissure; bh, basihyal; cb, ceratobranchial; ch, ceratohyal;
hs, hyosymplectic; m, Meckel’s cartilage; not, notochord; pq, palatoquadrate. The skeletons were positioned with anterior to the left (the same applied to the
other figures below).
(E and F) mir92a-MO-induced pharyngeal cartilage defects were rescued by coinjection ofmir92a duplex. We injected 4 ng of 92a-MO plus 1 nl of control miRNA
duplex ormir92a duplex at a concentration of 25 mM at the one-cell stage. Head morphology at 96 hpf (E) or Alcian blue-stained head cartilages at 80 hpf (F) were
shown. UIC, uninjected control embryos; also applied to the other figures. Scale bar in (E), 200 mm.
See also Figure S1.
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mir92a Derepresses Bmp Signaling by Targeting nog3formation by targeting mRNAs encoding proangiogenic
proteins (Bonauer et al., 2009). However, its function during
pharyngeal cartilage development is unknown. In this study,
we found that inactivation of mir92a activity results in loss of
pharyngeal cartilages due to a significant reduction in cell
proliferation, differentiation, and survival of pharyngeal chon-
drogenic progenitors. We found that mir92a targets nog3
mRNA encoding a Bmp antagonist. Knockdown of mir92a
reduces p-Smad1/5/8 levels but increases nog3 mRNA levels
in the pharyngeal region, resulting in a severe pharyngeal carti-
lage loss due to impaired proliferation and differentiation as
well as apoptosis of chondrogenic progenitors. Our data indi-
cate that mir92a-mediated regulation of nog3 is critical for
ingeniously balancing Bmp signal activity during pharyngeal
cartilage formation.
RESULTS
Zebrafish mir92a Is Expressed in CNC-Derived
Chondrogenic Progenitors
In zebrafish, twomir92amiRNAs,mir92a-1 andmir92a-2, though
identical in sequence, are encoded by the mir17-92 cluster and
the mir106a-92 cluster (Figure S1A available online), respec-
tively. The polycistronic transcripts of these two paralogous
clusters are conserved in stem-loop structures across vertebrate
species (Figure S1A), and the sequences of mature mir92a from
different species are identical except for a single nucleotide at 30284 Developmental Cell 24, 283–295, February 11, 2013 ª2013 Elsevend (Figure S1B). The evolutionary conservation of mir92a
miRNAs would suggest their similar functions in vertebrates.
We first examined the spatiotemporal expression pattern of
mir92a during zebrafish embryonic development. The expres-
sion of mir92a was weak around 24 hpf (Figure 1A). Later on,
its expression was detectable in the pharyngeal region as well
as in other tissues such as the head, spinal cord, blood vessels,
and pectoral fins (Figure 1A). In order to determine cell types ex-
pressing mir92a in the pharyngeal region, we performed double
fluorescence in situ hybridization withmir92a and GFP probes in
the Tg(fli1:EGFP) transgenic embryos. As shown in Figure 1B,
mir92a transcripts were localized in GFP-positive postmigratory
chondrogenic progenitors of pharyngeal arches as well as in
other types of cells including ectodermal and pouch endoderm
cells at 36–72 hpf, indicating that mir92a may be implicated in
pharyngeal cartilage development in zebrafish.
Knockdown ofmir92a Impairs Craniofacial Skeleton
Development
To investigate the developmental functions of mir92a, an anti-
sense morpholino oligonucleotide (92a-MO) was used to inacti-
vatematuremir92a. Injection of 92a-MO into embryos prevented
the locked nucleic acid (LNA)-modified mir92a antisense probe
from hybridization with endogenous mir92a (Figure S1C)
and blocked RT-PCR amplification of endogenous mir92a
(Figure S1F), suggesting that 92a-MO efficiently binds to and
thus inhibits function of mir92a transcripts.ier Inc.
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MO. By 96 hpf, compared to wild-type or standard negative
control MO (Ctrl-MO)-injected embryos, mir92a morphants
showed severely reduced pharyngeal arches and pectoral fins
with concomitant reduction of the head and eyes (Figures 1C
and S1D). These morphological defects remained when a mor-
pholino targeting p53 (p53-MO) was coinjected with 92a-MO
(Figures 1C and S1D), excluding the possibility that the observed
defects were caused by cell apoptosis due to nonspecific p53
activation by morpholinos (Nasevicius and Ekker, 2000).
To detect cartilage defects in mir92a morphants, we per-
formed Alcian blue staining. As shown in Figure 1D, almost all
of pharyngeal cartilages and most of dorsal neurocranium
were missing in mir92a morphants, except the residual para-
chordal cartilages adjacent to the cephalic portion of the noto-
chord. Furthermore, the morphants had a smaller endoskeletal
disc cartilage with loss of cleithrum and scapulocoracoid carti-
lages of pectoral fins (Figure S1E). These defects were not
observed in embryos injected with the control morpholino 92a-
rMO (Figures S1F–S1H), which has a sequence inverted from
92a-MO. Importantly, coinjection of mir92a duplex with 92a-
MO was able to restore pharyngeal cartilages (Figures 1E and
1F) and pectoral fin cartilages (Figures S1I and S1J). Taken
together, these data reveal that mir92a is essential for craniofa-
cial skeleton development in zebrafish embryos.
mir92a Knockdown Does Not Affect CNC Specification,
Migration, and Mesenchymal Condensation but Impairs
Chondrogenic Differentiation
To identify specific developmental stages at which mir92a is
required for pharyngeal cartilage formation, we set out to
examine the expression of several markers. We found that the
CNC specification marker foxd3 at the 5-somite stage and the
postmigratory CNC markers sox9a, dlx2, and hand2 at 24 hpf
or 36 hpf displayed normal levels of expression in mir92a mor-
phants (Figures 2A–2C), implying that neural crest induction
and migration were unaffected. The expression of goosecoid
(gsc), a marker for pharyngeal mesoderm (Lin et al., 2006),
occurred in correct domains even though the expression areas
were reduced in mir92a morphants (Figure 2D), suggesting
normal homing and differentiation of pharyngeal mesodermal
cells. The expression of col2a1, amarker for differentiating chon-
drocytes (Vandenberg et al., 1991; Yan et al., 2002), was reduced
in the ethmoid plate (ep) and trabeculae cranii (tc) of dorsal neu-
rocranial cartilages inmir92amorphants at 72 hpf (Figure 2E), but
completely lost in the ventral pharyngeal cartilages, indicating
that differentiation of the pharyngeal chondrogenic progenitors
was impaired due to loss of function of mir92a.
Then, we took other approaches to investigate pharyngeal
mesenchymal condensation and chondrogenic differentiation
processes in mir92a morphants. BODIPY-ceramide labeling
and peanut agglutinin (PNA) staining indicated that pharyngeal
mesenchymal cells in both mir92a morphants and control
embryos were experiencing condensation at 48 and 60 hpf
(Figures 2F and S2A). Since chondrogenic progenitors secrete
Col2 proteins during differentiation, we looked into production
of Col2 by immunostaining with anti-Col2 antibody. We found
that Col2 was hardly seen in the pharyngeal arches in mir92a
morphants at 66 hpf, as exampled for loss of Col2 in cellsDevelopm(dispersed) of the first arch-derived palatoquadrate (pq) and
the second arch-derived ceratohyal (ch) precartilage condensa-
tions (Figure 2G), which was indicative of a failure of chondro-
genic differentiation. However, the ethmoid plate (ep) and
trabeculae cranii (tc) cartilages of the neurocranium of mir92a
morphants had Col2, although the amount was reduced and
the cell shape was abnormal (Figure 2H), suggesting that differ-
entiation of neurocranial prechondrogenic cells is affected to
a lesser extent by loss of function ofmir92a. Visualizing filamen-
tous actin (F-actin) by Phalloidin staining showed that pharyn-
geal prechondrogenic cells in mir92a morphants at or before
60 hpf were arranged normally but disorganized at 66 hpf
(Figure S2B), also supporting the idea that chondrogenic differ-
entiation is impaired in mir92a morphants.
Taking these data together, we conclude that mir92a is not
required for the induction, migration, and condensation of CNC
cells, but is indispensable for the differentiation of the pharyngeal
chondrogenic progenitors.
Pharyngeal CartilageDefects bymir92a Inactivation Are
Independent of Blood Flow
The existence ofmir92a transcripts in blood vessels of zebrafish
embryos (Figure 1A) and the appearance of a heart edema in
mir92amorphants (Figure 1C) raise a possibility that pharyngeal
cartilage defects in the morphants are indirectly caused by
defective blood flow. To address this issue, we first knocked
down mir92a in Tg(flk1:EGFP);Tg(gata1:DsRed) double trans-
genic embryos, which express enhanced green fluorescent
protein (EGFP) in blood vasculature and red fluorescence protein
in hematopoietic progenitors (Wang et al., 2011). Results indi-
cated that blood vessels and circulation in the branchial and
trunk regions appeared normal inmir92amorphants as observed
at 36–48 hpf (Figures S2C–S2F). Then, we performed mir92a
knockdown in cloche (clo), a mutant line that lacks head vessels
and has few blood cells but retains pharyngeal cartilages (Liao
et al., 1997; Stainier et al., 1995). Inactivation of mir92a was still
able to cause missing of pharyngeal cartilages (Figure S2G).
These results strongly support the idea that mir92a is required
for pharyngeal cartilage formation independent of blood flow.
mir92a Deficiency Impairs Proliferation and Survival
of Chondrogenic Progenitors
We dynamically observed pharyngeal cartilage development
inmir92amorphants in the Tg(fli1:EGFP) transgenic background.
In transgenic embryos injectedwithCtrl-MO,GFP-positive chon-
drogenic progenitors migrated into seven pharyngeal segments
at 36 hpf, aggregated together to formprechondrogenic conden-
sations at 48 hpf, differentiated into chondrocytes about 60 hpf,
and organized orderly in chondrocyte stacks at 80 hpf (Figure S3,
upper panel). In mir92a morphants, the structure of the pharyn-
geal segments at 36 hpf appeared normal; these segments re-
mained visible at 48 and 60 hpf, but their sizes were reduced;
at 80 hpf, most pharyngeal arches were disappeared (Figure S3,
lower panel). These results indicate that in mir92a morphants
CNC cells can migrate into the pharyngeal arches and chon-
drogenic progenitors can condense but fail to form cartilages.
The size reduction of the pharyngeal segments inmir92amor-
phants (Figure S3) suggests that cell proliferation and survival
are interfered. Then, we first investigated the role of mir92a inental Cell 24, 283–295, February 11, 2013 ª2013 Elsevier Inc. 285
Figure 2. Inactivation of mir92a Affects Late but Not Early Steps of Pharyngeal Cartilage Development
(A–E) The expression pattern of variousmarkers in uninjected (UIC) or 92a-MO-injected (4 ng) embryos as detected bywhole-mount in situ hybridization. Embryos
in (A) and (B) were dorsal views with anterior to the top; the other embryos were lateral views with anterior to the left. The indicated ratio was the number of
embryos with the shown representative phenotype/total number of observed embryos. Red and yellow circles in (D) indicated the pharyngeal region and pectoral
fin, respectively. In (E), red and green circles indicated the pharyngeal arches and the cartilage capsule of the ears, and red arrowhead indicated the ethmoid plate
and trabeculae cranii of dorsal neurocranial cartilages.
(F) The prechondrogenic condensation inmir92amorphants appeared normal. Embryoswere injected at the one-cell stagewith 4 ng 92a-rMOor 92a-MO, treated
with BODIPY-ceramide at the end of gastrulation, and imaged by confocal microscopy at 48 hpf. The pharyngeal region was laterally viewedwith dorsal to the top
and anterior to the left. Extracellular space and cavity looked black. Arrows indicated aortic arches. The boxed area in the left image was enlarged and presented
in the right. Scale bars, 20 mm.
(G) Detection of Col2 protein in pharyngeal prechondrogenic progenitors. Tg(fli1:EGFP) transgenic embryos were injected with 4 ng 92a-rMO or 92a-MO at the
one-cell stage and coimmunostained with anti-GFP and anti-Col2 antibodies. The palatoquadrate (pq) and ceratohyal (ch) precartilages were shownwith anterior
to the top. Arrows in the right panel indicated eyes. Scale bars, 20 mm.
(H) Detection of Col2 in the neurocranial cartilages. Wild-type embryos, injected as in (G), were immunostained with anti-Col2 antibody. For each panel, the left
was the dorsal view of the head region with anterior to the top and the right represented an enlargement of the area boxed in the left. Dorsal view, anterior to the
top. The boxed area in the left image was presented at higher magnification in the corresponding right image. ch, ceratohyal; ep, ethmoid plate; pq, palato-
quadrate; tc, trabeculate cranii. Scale bars, 50 mm (left) and 5 mm (right).
See also Figure S2.
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mir92a Derepresses Bmp Signaling by Targeting nog3the proliferation of pharyngeal chondrogenic progenitors by per-
forming bromodeoxyuridine (BrdU) incorporation assays in
Tg(fli1:EGFP) embryos at 40 hpf. Immunofluorescence with
a BrdU antibody detected a dramatic decrease of the positive286 Developmental Cell 24, 283–295, February 11, 2013 ª2013 Elsevcell number in the pharyngeal region of mir92a morphants at
42 hpf (Figures 3A and 3A0), suggesting impeded proliferation
of prechondrocytes. Immunostaining for phosphorylated histone
H3 (pH3) indicated that mir92a morphants had moreier Inc.
Figure 3. Inhibition of mir92a Activity Impairs Proliferation and Survival of Chondrogenic Progenitors
(A–B0) Representative confocal sections showing BrdU- or pH3-positive cells (red) in the pharyngeal region. 92a-rMO or 92a-MO-injected (4 ng) Tg(fli1:EGFP)
transgenic embryoswere coimmunostainedwith anti-GFP and anti-BrdU (A) or anti-pH3 antibodies at 42 hpf (B). The images shownwere lateral views for the first
two pharyngeal arches (PA1 and PA2) (similarly labeled in C). Scale bars, 20 mm. The percentage of BrdU- or pH3-positive cells among GFP-positive pharyngeal
chondrogenic progenitors, based on five embryos (one to two images each) for each group, were shown in (A0) and (B0). **p < 0.01; ***p < 0.001.
(C and C0) Detection of apoptotic cells in the pharyngeal regions. Tg(fli1:EGFP) transgenic embryos were injected with 92a-rMO, 92a-MO, or 92a-MO plus p53-
MO (at 4 ng each) and collected at indicated stages for TUNEL assay. Representative images were shown in (C). The ratio of TUNEL- and GFP-positive cells
(orange) to GFP-positive cells in the first and second pharyngeal arches were calculated from five embryos with one to two images each and presented in (C).
Scale bars, 20 mm.
See also Figure S3.
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mir92a Derepresses Bmp Signaling by Targeting nog3pH3-positive cells in the pharyngeal region (Figures 3B and 3B0),
which implies that the cell cycle of pharyngeal chondrogenic
progenitors is arrested during mitosis due tomir92a inactivation.
In conclusion, loss of mir92a activity inhibits cell proliferation
within the pharyngeal arches, leading to a reduction of the chon-
drogenic progenitor number.
We then looked into apoptosis in the pharyngeal region of 92a-
MO-injected Tg(fli1:EGFP) transgenic embryos by TUNEL assay
at different stages (Figures 3C and 3C0). mir92a morphants did
not show an increase of apoptotic cells in the pharyngeal arch
region at or before 48 hpf (Figure 3C, top two panels). At 54
hpf, the number of apoptotic prechondrogenic cells in the mor-
phants was slightly increased, which could be suppressed by
p53-MO coinjection (Figure 3C, the third panel). At 60 hpf,
a further increase of the apoptotic cells was observed in themor-
phants, which could not be completely prevented by p53-MO
coinjection (Figure 3C, the fourth panel). We hypothesize thatDevelopmapoptosis of chondrogenic cells also contributes to loss of
pharyngeal skeleton in the absence of mir92a, which is not
wholly dependent on p53 activation.
mir92a Acts Upstream of Bmp Signaling to Regulate
Pharyngeal Cartilage Formation
Bmp signaling is essential for cell proliferation and differentiation
in the development of the pharyngeal skeleton (Alexander et al.,
2011; Retting et al., 2009; Yoon et al., 2005). To detect whether
Bmp signaling is influenced by mir92a knockdown during
pharyngeal cartilage development, we first examined the spatial
distribution of phosphorylated Smad1/5/8 (p-Smad1/5/8), the
intracellular effectors of Bmp signaling, in the sections of
Tg(fli1:EGFP) embryos at 42 hpf. During pharyngeal cartilage
development, a gradient of p-Smad1/5/8 was observed from
posterior to anterior and ventral to dorsal in the pharyngeal region
in wild-type embryos (Figure 4A) as previously describedental Cell 24, 283–295, February 11, 2013 ª2013 Elsevier Inc. 287
Figure 4. mir92a Regulates Bmp Signaling during Pharyngeal Cartilage Formation
(A–C) p-Smad1/5/8 levels were reduced in the pharyngeal region of mir92a morphants. 92a-rMO and 92a-MO-injected (4 ng) Tg(fli1:EGFP) embryos at 42 hpf
were stained for p-Smad1/5/8 using anti-p-smad1/5/8 and DAPI (A, B). The pharyngeal region (A) and trunk somite muscle (B) were observed after immuno-
staining by confocal microscopy. p-Smad1/5/8 in cell lysis of head region at 42 hpf was detected by western blotting (C). Scale bars, 20 mm.
(D) Embryos depleted of Bmp activity showed severe pharyngeal cartilage defects. Dorsomorphin-treated wild-type (WT) or heat-shocked Tg(hsp70l:dnBmpr-
GFP) transgenic live embryos were photographed at 96 hpf and Pharyngeal cartilages of heat-shocked transgenic embryos at 80 hpf were detected with Alcian
blue. Scale bars, 200 mm.
(E) Embryos depleted of Bmp activity showed a reduced proliferation of pharyngeal chondrogenic progenitors. BrdU-treated Tg(fli1:EGFP) transgenic embryos
were stained at 42 hpf with anti-BrdU (red) and anti-GFP antibodies (green). The pharyngeal regions were observed by confocal microscopy. Scale bar, 20 mm.
(F) Deficiency of pharyngeal chondrogenic progenitor differentiation in dorsomorphin-treated embryos. Confocal sections of the palatoquadrate (pq) and
ceratohyal (ch) cartilages of Tg(fli1:EGFP) transgenic embryos. These embryos were treated with DMSO or 10 mM dorsomorphin at 36 hpf and probed with anti-
GFP and anti-Col2 antibodies at 66 hpf. Scale bars, 20 mm.
(G and H) 92a-MO-induced pharyngeal cartilage defects were rescued by bmp4 overexpression. Wild-type embryos were injected with 4 ng 92a-MO alone or
together with 7 pg bmp4mRNA at the one-cell stage and stained with Alcian blue for cartilages at 80 hpf. Coinjected embryos showed different levels of recovery
of neurocranium and pharyngeal cartilages. Representative cartilage phenotypes (BR0-BR3) were shown in (G) and their ratios were shown in (H).
See also Figure S4.
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mir92a Derepresses Bmp Signaling by Targeting nog3(Alexander et al., 2011; Payne-Ferreira and Yelick, 2003). In
contrast, mir92a morphants displayed significantly decreased
p-Smad1/5/8 levels in the same region (Figure 4A). In contrast,
the p-Smad1/5/8 level was not obviously changed in the somite
muscle ofmir92amorphants (Figure 4B), demonstrating a tissue-
specific effect of mir92a knockdown on Bmp/Smad signaling.
We then examined the p-Smad1/5/8 levels in the head region
at 42 hpf by western blotting, which also revealed a marked
reduction of p-Smad1/5/8 level with unaltered total Smad1/5/8
levels in mir92a morphants (Figure 4C). Therefore, loss of
mir92a attenuated Bmp signaling in pharyngeal chondrogenic
progenitors.
Several Bmp ligands are expressed in the pharyngeal pouches
after chondrogenic progenitors migrate into the pharyngeal
region (Holzschuh et al., 2005). We looked into the effect of
Bmp signaling on pharyngeal cartilage development by overex-
pressing the dominant negative Bmp receptor (dnBmpr) using
the temperature-inducible transgenic line Tg(hsp70l:dnBmpr-
GFP) (Pyati et al., 2005) or treating wild-type embryos with the
Bmp signaling inhibitor dorsomorphin after NC migration (Yu
et al., 2008). Heat-shocked Tg(hsp70l:dnBmpr-GFP) embryos
or dorsomorphin-treated wild-type embryos exhibited pheno-
types at later stages, including a small head, severely reduced
cartilage elements (Figure 4D), and shorter and smaller pectoral
fins (Figure S4A), which were similar to those in mir92a mor-
phants. Like mir92a morphants, the pharyngeal chondrogenic
progenitors in dorsomorphin-treated embryos also showed
poor proliferation ability at 42 hpf (Figure 4E) and deficiency of
differentiation at 66 hpf (Figure 4F), while cell apoptosis was
not increased at 42 hpf (Figure S4B). Importantly, coinjection of
bmp4mRNA efficiently rescued the pharyngeal cartilage forma-
tion in mir92a morphants (Figures 4G and 4H). Based on these
observations, we propose thatmir92a participates in pharyngeal
cartilage formation by positively regulating Bmp signaling.
mir92a Directly Targets nog3 mRNA In Vitro and In Vivo
To understand the molecular mechanism by which mir92a
regulates Bmp signaling during pharyngeal cartilage develop-
ment, we set to identify the potential mir92a targets that have
the ability to attenuate Bmp signaling. In animals, recognition
sites formiRNAs are located in the 30 UTR aswell as in the coding
region of mRNAs, and miRNAs can suppress target gene
expression by directly binding to and degrading the coding
sequence (Duursma et al., 2008; Forman et al., 2008; Hafner
et al., 2010; Lewis et al., 2005; Liu et al., 2012). We looked for
potential mir92a targets based on two criteria: expression in
pharyngeal arches and the existence of mir92a binding sites in
30 UTR or in the coding region. Using online target predic-
tion algorithm (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/
submission.html), we analyzed the mRNAs encoding some
known Bmp antagonists, including nog1, nog2, nog3, chordin,
follistatin a, follistatin b, follistatin-like 1a, smad6a, and smad7.
Consequently,we found that onlynog3mRNAcontains twoputa-
tive binding sites of mir92a, BS1 in the coding sequence (CDS)
adjacent to the stop codon and BS2 in the 30 UTR (Figure 5A).
We generated an EGFP-nog3-ed30UTR reporter construct that
included both BS1 and BS2 in the expanded 30 UTR (Figure S5A).
As shown in Figure 5B, injection of synthetic EGFP-nog3-
ed30UTR mRNA alone or together with Ctrl duplex into one-cell-Developmstage embryos gave rise to strong EGFP fluorescence at 24
hpf; its coinjection with mir92a duplex markedly lowered EGFP
fluorescence levels while coinjection with mir92a duplex and
92a-MO reconverted GFP fluorescence levels. Western blot anal-
ysis using a GFP antibody confirmed fluorescence microscopic
results (Figure 5C). Furthermore, GFP fluorescence generated
by injection of EGFP mRNA lacking the expanded 30 UTR of
nog3was unaltered by coinjection ofmir92a duplex (Figure S5B).
These results indicate that nog3mRNA can be efficiently targeted
by mir92a through one or both of the putative binding sites.
To identify the functional recognition sites formir92a, wemade
another three EGFP reporter constructs (Figure S5A), EGFP-
nog3-BS1 (containing BS1 only), EGFP-nog3-mBS1 (containing
mutations in BS1), and EGFP-nog3-30UTR (containing BS2 only).
Injection ofmir92a duplex greatly reduced GFP expression from
EGFP-nog3-BS1, but had no effect on EGFP-nog3-mBS1
expression (Figures 5D and 5E), which suggests that BS1
residing within nog3 CDS is recognized by mir92a. In contrast,
GFP expression of EGFP-nog3-30UTR was not reduced by coin-
jection withmir92a duplex (Figure S5C), implying that BS2 inside
the 30 UTR of nog3 mRNA is not essential for mir92a-regulated
nog3 expression. Furthermore, zebrafish smad6a and smad7,
which can prevent ligand-induced activation of Bmp signaling
(Bell et al., 2003; Mowbray et al., 2001; Pogoda and Meyer,
2002), did not possess mir92a binding sites (data not shown),
and the expression of the GFP reporter with either of their 30
UTR could not be inhibited by injection ofmir92a duplex (Figures
S5D and S5E). Therefore, mir92a selectively targets mRNAs of
specific Bmp antagonists.
We examined the expression of nog3 in mir92a morphants by
in situ hybridization. As shown in Figures 5F and 5G, injection of
92a-MO led to elevated endogenous levels of nog3 expression
in the pharyngeal region at 42 and 48 hpf, while injection of
synthetic mir92a duplex significantly decreased nog3 expression
levels. Obviously, nog3 mRNA stability in the pharyngeal arches
is subjected to regulation by mir92a in zebrafish embryos. By
contrast, the pharyngeal pouch expression of bmp2b, bmp4,
and Zn-5 (pharyngeal endodermal marker) was normal in mir92a
morphants (Figures S5F and S5G), which implied that mir92a is
not required for pharyngeal endoderm development at this stage.
nog3 Is Required for Chondrogenic Progenitor Survival
by Restricting Bmp Signaling during Pharyngeal
Cartilage Development
Next, we investigated the function of nog3 in pharyngeal cartilage
development using a translation block morpholino (nog3-MO),
whichwas able to effectively inhibit the expression of the reporter
pCMV-nog3-GFP (Figure S6A). Stainingwith Alcian blue at 80 hpf
indicated that in nog3 morphants the ventral pharyngeal
cartilages were severely reduced or disappeared in a dose-
dependent manner, while the dorsal neurocranium appeared
slightly shorter and misshaped (Figure 6A). The defects caused
by 1 ng nog3-MO injection could be rescued coinjection of
nog3 mRNA, suggesting the specificity of the nog3 knockdown
(Figure S6B). As an antagonist of Bmp ligands, nog3 deficiency
would result in excessBmpsignals and consequently pharyngeal
cartilage defects. We indeed found that nog3-MO-induced
pharyngeal cartilage defects were efficiently rescued by re-
ducing Bmp signaling via dorsomorphin treatment (Figures 6Bental Cell 24, 283–295, February 11, 2013 ª2013 Elsevier Inc. 289
Figure 5. mir92a Directly Targets nog3 mRNA In Vitro and In Vivo
(A) The two putative binding sites of mir92a in nog3 mRNA. The position of the last base of the stop codon was numbered 0.
(B andC) The expression of the reporterGFP-nog3-ed30UTRwas inhibited bymir92a duplex. We injected 100 pg of the reporter mRNA at the one-cell stage alone
or together with 1 nl of control miRNA duplex (Ctrl duplex),mir92a duplex, ormir92a duplex (20 mM) plus 4 ng 92a-MO, and injected embryos were observed for
GFP fluorescence at 24 hpf (B). The GFP protein levels at 24 hpf were also examined by western blot with the anti-GFP antibody (C). Scale bar, 1 mm.
(D and E) The expression of EGFP-nog3-BS1 but not EGFP-nog3-mBS1 reporter was inhibited by injection ofmir92a duplex. The embryos were similarly injected
and observed (D) as in (B). Scale bar, 1 mm. The GFP expression levels at 24 hpf were also examined by western blot with the anti-GFP antibody (E).
(F and G) Alteration of nog3mRNA levels in embryos injected with 4 ng 92a-MO or 10 mM 92a duplex (1 nl per embryo). Uninjected (UIC) or injected embryos at 42
(F) and 48 hpf (G) were probed using the nog3 antisense probe. Ventral views with anterior to the left. The ratio of embryos with altered expression to the total was
indicated.
See also Figure S5.
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mir92a Derepresses Bmp Signaling by Targeting nog3and 6C). Interestingly, nog3-MO-induced head skeletal defects
could be rescued by coinjection of p53-MO (Figure S6C), which
could be explained that excess Bmp signals due to deficiency
of their antagonists may trigger apoptosis as demonstrated in
limb mesenchyme apoptosis (Bastida et al., 2004; Guha et al.,
2002; Macias et al., 1997; Zuzarte-Luı´s et al., 2004). Apoptotic
analysis by TUNEL assay in Tg(fli1:EGFP) transgenic embryos
showed that nog3morphants had many more TUNNEL-positive
apoptotic cells in the pharyngeal arches, which was effectively
suppressed by dorsomorphin treatment (Figures 6D and 6E).
Taken together, our data support the idea that nog3 plays a vital
role in chondrogenic progenitor survival during pharyngeal devel-
opment by restricting Bmp signaling.
Bmp Signaling Is Balanced bymir92a and nog3 during
Pharyngeal Cartilage Formation
We have demonstrated in the above that loss of mir92a activity
leads to elevated expression of endogenous nog3 and
decreased levels of p-Smad1/5/8 in the pharyngeal region. To
further prove the hypothesis that the attenuated Bmp signaling
in mir92a morphants results from an increase of nog3 expres-290 Developmental Cell 24, 283–295, February 11, 2013 ª2013 Elsevsion, we coinjected 92a-MO with nog3-MO. The ventral
pharyngeal and dorsal neurocranium appeared almost normal
in 41% of coinjected embryos at 80 hpf, and the pharyngeal
cartilage formation of the other embryos was also partly
rescued (Figures 7A and 7B). Wild-type embryos injected with
synthetic mir92a duplex caused pharyngeal cartilage defects
(Figure 7C), which partially phenocopied nog3 morphants
(Figure 6A) and could be rescued to some extent by dorsomor-
phin treatment (Figures S7 and 7D). Furthermore, like nog3-MO
injection, mir92a duplex injection induced apoptosis in the
pharyngeal region as assayed at 42 hpf, and this effect was
also alleviated by dorsomorphin treatment (Figures 7E and
7F). Taken together, these findings support the notion that
mir92a regulates pharyngeal cartilage formation by balancing
Bmp signaling via nog3.
DISCUSSION
In this study, we uncover an essential role of mir92a in pharyn-
geal cartilage development of zebrafish embryos. Inactivation
of mir92a by an antisense morpholino (92a-MO) results in lossier Inc.
Figure 6. Knockdown of nog3 Derepresses Bmp Signaling and Induces Chondrogenic Progenitor Apoptosis
(A) Pharyngeal cartilage defects in nog3 morphants. Wild-type embryos were injected at the one-cell stage with different doses of nog3-MO and stained for
cartilages with Alcian blue.
(B and C) nog3-MO-induced cartilage defects were alleviated by inhibition of Bmp activity with dorsomorphin. nog3-MO-injected (1 ng) embryos at 36 hpf were
treated in DMSO or dorsomorphin of different concentrations and stained for cartilages at 80 hpf with Alcian blue. The extents of cartilage defects were cate-
gorized into four groups, DR1–4 (B), and the ratio of each group was shown in (C).
(D and E) Detection of apoptotic cells in nog3morphants. Tg(fli1:EGFP) transgenic embryos were injected at the one-cell stage with 1 ng nog3-rMO or nog3-MO
and subjected to TUNEL assay (red) at 42 hpf. For dorsomorphin treatment, injected embryos at 36 hpf were incubated with 5 mM dorsomorphin until 42 hpf. The
images shown were lateral views of the first two pharyngeal arches (PA1 and PA2) (D). Scale bar, 20 mm. The percentage of TUNEL-positive cells among the total
number of pharyngeal chondrogenic progenitors (GFP-positive) in the imaged region was calculated based on five embryos each group (E). ***p < 0.001; error
bars indicated SD.
See also Figure S6.
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mir92a Derepresses Bmp Signaling by Targeting nog3of pharyngeal cartilage elements due to impaired prolifera-
tion, differentiation, and ultimate apoptosis of chondrogenic
progenitors.
mir92a is a component of the mir-17-92 cluster, which
possesses oncogenic activity and can influence cell proliferation
and tumorigenesis (He et al., 2005; O’Donnell et al., 2005).
mir92a itself has also been demonstrated to increase the prolif-
eration of 32D murine myeloid cells and human hepatocellular
carcinoma-derived cell lines (Manni et al., 2009; Shigoka et al.,
2010). We show that loss ofmir92a activity inhibits chondrogenic
progenitor proliferation within the pharyngeal region and ulti-
mately causes loss of the pharyngeal cartilage elements in
zebrafish embryos. Therefore, the role of mir92a in maintaining
cell proliferation is evolutionally conserved between different
species and cell types.
Our data indicate that mir92a in zebrafish embryos neither
regulates induction and migration of cranial crest cells norDevelopmimpedes the initiation of chondrogenic progenitor condensa-
tion during pharyngeal cartilage formation. Instead, it controls
the proliferation, differentiation, and survival of chondrogenic
progenitors. Three pieces of evidence support the idea that
mir92a promotes chondrogenic progenitor proliferation and
differentiation by augmenting Bmp activity in the pharyngeal
region. First, inactivation of mir92a by an antisense morpholino
or inhibition of Bmp activity by application of the Bmp inhi-
bitor dorsomorphin can impair the proliferation and dif-
ferentiation of pharyngeal chondrogenic progenitors at early
stages of pharyngeal development. Second, inactivation of
mir92a leads to a decrease of the Bmp receptor-activated
Smads1/5/8 in the pharyngeal region. Third, 92a-MO-blocked
pharyngeal cartilage formation could be reversed by over-
expression of bmp4. Although mir92a inactivation does not
accelerate pharyngeal chondrogenic cell apoptosis during
early chondrogenesis (before condensation and differentiation),ental Cell 24, 283–295, February 11, 2013 ª2013 Elsevier Inc. 291
Figure 7. Genetic Interactions among
mir92a, nog3, and Bmp Activity during
Pharyngeal Cartilage Development
(A and B) 92a-MO-induced pharyngeal cartilage
defects were rescued by coinjection of nog3-MO.
Embryos injected with 4 ng 92a-MO alone or
together with 0.1 ng nog3-MO at the one-cell
stage, and harvested for Alcian blue staining at 80
hpf. Different degrees of rescue effects (NR0–NR2)
were observed (A), and the ratio of each group was
shown in (B).
(C) Ectopic expression of mir92a resulted in
pharyngeal cartilage defects. Wild-type embryos
were injectedwith 10 mMmir92a duplex at the one-
cell stage, and stained at 80 hpf for cartilages with
Alcian blue. Pharyngeal cartilage defects were
categorized into groups P1–P3 (C), and the ratio of
each group was indicated in the corresponding
picture.
(D) mir92a duplex-induced pharyngeal cartilage
defects were compromised by dorsomorphin
treatment. Embryos injected with 10 mM mir92a
duplex were treated in 5 mM dorsomorphin at 36
hpf and stained at 80 hpf for cartilage with Alcian
blue. The percentage of embryos with different
degrees of cartilage defects was calculated.
(E and F) mir92a duplex-induced apoptosis in the
pharyngeal region. Tg(fli1:EGFP) transgenic em-
bryos injected with 1 nl of 10 mM mir92a duplex
were treated in 5 mM dorsomorphin at 36 hpf, sub-
jected to TUNEL assay at 42 hpf, and observed by
confocal microscopy. The representative images
were lateral views of the first two pharyngeal
arches (PA1andPA2) (E).Scalebar, 20mm.The ratio
of TUNEL- and GFP-positive cells (orange) to GFP-
positive cells in the first and second pharyngeal
arches were calculated from five embryos with
one to two images each and presented in (F).
See also Figure S7.
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morphants at later stages. This implies that an appropriate level
of Bmp activity during pharyngeal chondrogenesis must be
maintained for the survival of cartilage cells. Our findings are
consistent with the requirement of Bmp signaling in mouse
endochondral bone formation (Retting et al., 2009; Yoon
et al., 2005).
Since miRNAs primarily function to inhibit mRNA translation
of target genes, mir92a would not directly target an effector of
Bmp signaling pathway. By looking into sequences of genes
encoding Bmp antagonists, we found that zebrafish nog3 is
a direct target of mir92a. The physiological function of nog3
during cranial skeletal development has not been previously
investigated. Our in vitro and in vivo experiments confirmed
that nog3 is a direct target of mir92a in the pharyngeal region.
Loss ofmir92a activity increases the amount of nog3 transcripts
in the pharyngeal region, leading to synthesize more Nog3
protein. The increased amount of Nog3 protein in mir92a mor-
phants antagonize Bmp activity by binding to Bmp ligands ac-
cessing to chondrogenic progenitors. This is supported by the
findings that double knockdown of mir92a and nog3 conquers
pharyngeal cartilage defects caused by either of single knock-
down. On the other hand, overexpression of mir92a duplex
may accelerate nog3 mRNA degradation, thus derepressing292 Developmental Cell 24, 283–295, February 11, 2013 ª2013 ElsevBmp activity. Derepression of Bmp activity by nog3 knockdown
or mir92a overexpression can induce apoptosis of pharyngeal
chondrogenic progenitors. This is not surprising since ectopic
Bmps have been demonstrated to trigger apoptosis in the
undifferentiated mesenchyme of chicken limb buds with subse-
quent loss of skeletal elements (Macias et al., 1997). In zebrafish
embryos, several other Bmp antagonists, including follistatin a
(fsta) (http://zfin.org/cgi-bin/webdriver?MIval=aa-fxfigureview.
apg&OID=ZDB-FIG-050630-10629), follistatin b (fstb)/follistatin-
like 2 (Dal-Pra et al., 2006), follistatin-like 1a (fstl1a) (Dal-
Pra et al., 2006), follistatin-like 1b (fstl1b) (http://zfin.org/
cgi-bin/webdriver?MIval=aa-fxfigureview.apg&OID=ZDB-FIG-
050630-10128), chordin (Sperber and Dawid, 2008), and
chordin-like 2 (Branam et al., 2010), have been found to be
expressed in the pharyngeal region. How these Bmp antag-
onists collaboratively regulate Bmp activity during pharyngeal
cartilage formation will be an interesting issue for further studies.
In summary, our study discovers mir92a-nog3-Bmp regula-
tory relationships in pharyngeal cartilage development. nog3
acts to repress Bmp activity, presumably preventing apoptosis
since nog3 knockdown promotes apoptosis. On the other
hand, mir92a functions to avoid excess nog3 message,
thus preserving sufficient Bmp activity for the proliferation
and differentiation of chondrogenic progenitors. Through thisier Inc.
Developmental Cell
mir92a Derepresses Bmp Signaling by Targeting nog3mechanism, Bmp activity is well balanced in the pharyngeal
region. However, further studies should be done to investigate




Wild-type embryos were obtained from natural matings of zebrafish Tuebingen
strain. Embryos were raised in Holtfreter’s solution at 28.5C, and staged by
morphology as described (Kimmel et al., 1995). Tg(hsp70l:dnBmpr-GFP)
transgenic embryos express a dominant-negative Bmp receptor fused to
GFP upon heat shock stimulation (Pyati et al., 2005). Tg(fli1:EGFP) transgenic
embryos express EGFP in cranial neural crest derivatives as well as in blood
vessels, which is controlled by the fli1 promoter (Lawson and Weinstein,
2002). The cloche (clo) mutant and the Tg(flk1:EGFP/gata1:dsRed) double
transgenic line were kindly provided by Prof. Feng Liu at Institute of Zoology,
Chinese Academy of Sciences. Our work involving zebrafish embryo collection
and analysis was carried out in accordance with and approved through the
Animal Care Committee at the Institute of Zoology, Chinese Academy of
Sciences.
RNA Synthesis
mRNAs were in vitro synthesized from corresponding linearized plasmids
using mMESSAGE mMACHINE Kit (Ambion). mir92a duplex and control
miRNA duplex (Ctrl duplex) were designed and synthesized by Shanghai
GenePharma Co, Ltd. Generation of constructs and RNA duplex sequences
were described in Supplemental Experimental Procedures. Digoxigenin-
UTP-labeled antisense RNA probes were in vitro transcribed using
MEGAscript Kit (Ambion) according to the manufacturer’s instructions. The
Digoxigenin-labeled LNA antisensemir92a probe was synthesized by Exiqon.
Morpholinos, Microinjection, andWhole-Mount In Situ Hybridization
Morpholinos were purchased from Gene Tools, LLC, and their sequences
were listed in Supplemental Experimental Procedures. Microinjection and
whole-mount in situ hybridization were performed as before (Jia et al., 2008;
Wienholds et al., 2005). Double fluorescence in situ hybridization was per-
formed as previously reported (Welten et al., 2006). Anti-digoxigenin-POD
(11633716001, Roche) and anti-fluorescein-POD (11426346910, Roche)
were used as primary antibodies to detect digoxigenin-labled mir92a probes
and fluorescein-labeled GFP probes, respectively. The signal was detected
by TSA system, including Cyanine 3 amplification reagent (601603,
PerkinElmer), Cyanine 5 amplification reagent (609968, PerkinElmer), and
13 plus amplification diluents (602566, PerkinElmer).
Embryonic Treatments
For the induction of dnBmpr expression, Tg(hsp70l:dnBmpr-GFP) embryos
were subjected to 40C heat shocks for 30 min at 33 hpf (hours postfertiliza-
tion), 40, 48, and 56 hpf, and then harvested at 80 hpf for fluorescence obser-
vation and Alcian blue staining as previously described (Ellies et al., 1997).
Dorsomorphin (P5499, Sigma) was dissolved in DMSO. Embryos at 36 hpf
were raised in 10 mM dorsomorphin under dark conditions for 16 hr with
change of fresh drug buffer once every 8 hr, and then washed and fixed for
other manipulations at 80 hpf. For blocking Bmp activity in nog3 morphants,
nog3-MO-injected embryos were treated with dorsomorphin at varying doses.
For immunostaining, Tg(fli1:EGFP) embryos were treated with 10 mM dorso-
morphin at 36 hpf and harvested at 42 hpf for other manipulations.
For BODIPY-ceramide labeling, living embryos at 48 hpf were incubated in
BODIPY@FL C5-ceramide (D-3521, Molecular Probes) at 10 mM in Embryo
Rearing Medium (ERM) with HEPES for 30 min as described by Cooper
et al. (1999), washed in ERM three times (10 min each), and then placed in
1% agarose for confocal microscopy.
Quantitative Stem-Loop RT-PCR
Stem-loop RT-PCR was performed as previously described (Chen et al., 2005;
Liu et al., 2012). Information of primer sequences are given in Supplemental
Experimental Procedures.DevelopmWhole-Mount Immunostaining
For the detection of p-Smad1/5/8 and Col2 expression, 92a-rMO- or 92a-MO-
injected Tg(fli1:EGFP) embryos were harvested at 42 hpf or 66 hpf, fixed
overnight at 4C with paraformaldehyde, dehydrated with methanol, and
stored at 20C. Then following rehydration, embryos were permeabilized
with proteinase K (10 mg/ml) for 30 min, incubated in blocking buffer (2%
BSA, 5% normal goat serum, 0.1% Tween-20 in PBS) for 1 hr. Embryos
were stained with anti-p-Smad1/5/8 (1:200; 9511, Cell Signaling Technology)
or anti-Collagen type II (Col2) (1:100; II-116B3, DSHB) antibodies.
For peanut agglutinin (PNA) staining, embryos fixed at 60 hpf were incubated
overnight at 4C in 20 mM PNA conjugated with Alexa Fluor 568 ((Molecular
Probes, L32458), 1% BSA, 2 mM CaCl2, 2 mM MgCl2, and washed in PBST.
The stained embryos were laterally placed and imaged by confocal micros-
copy with a focus on the first two pharyngeal arches.
Proliferation and Apoptosis Analyses
Whole-mount immunostaining of incorporated BrdU and pH3 were performed
as previously reported (Laguerre et al., 2005; Vihtelic et al., 2001). For pH3
detection, Tg(fli1:EGFP) embryos were harvested at 42 hpf, fixed with 4%
paraformaldehyde, and washed with 0.3% Triton X-100 and 0.1% Tween-20
in PBS for 20 min before immunostaining. Then, embryos were stained with
anti-pH3 (1:1,000; 3377, Cell Signaling Technology) and mouse anti-GFP
(1:1,000, A11120, Molecular Probes) antibodies.
For BrdU labeling experiments, Tg(fli1:EGFP) embryos injected with indi-
cated MOs or treated with dorsomorphin were placed in 10 mM BrdU at 40
hpf for 25 min and harvested at 42 hpf. Incorporated BrdUs and GFP were
detected using anti-BrdU (1:1,000; B2531, Sigma) and rabbit anti-GFP anti-
bodies (1:1,000, a gift from Dahua Chen Lab) by whole-mount immunostaining
as previously described (Laguerre et al., 2005).
Apoptosis were determined by TUNEL assay. Tg(fli1:EGFP) embryos were
harvested at 42 hpf for TUNEL labeling using In Situ Cell Death Detection Kit,
TMR red (12156792910, Roche) according to the manufacturer’s instruction.
For GFP-, BrdU-, pH3-, or TUNEL-positive cell count, images were analyzed
with ImageJ software. Significance was analyzed using the unpaired t test.
Time-Lapse Imaging
Tg(fli1:EGFP) embryos were anaesthetized at 40 hpf and embedded in 0.8%
low-melt agarose. Confocal stack pictures of the pharyngeal arch region
were taken at indicated time points using META Zeiss 510 confocal micro-
scope (203 objective).
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